Hanall Biopharma
KOSPI · Healthcare · 3조원
Overtime ₩48,0000.00%
Price
51,600원
48,150원
Apr 24, 26Jul 21, 26
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩39.2B-2.1%
Operating Income₩100M-88.1%
Net Income-₩1.7BTurned to loss
3/'26 vs prev quarter
Company Health
Operating Margin+0.2%
Cash on Hand362억원
PSR17.3x
PBR17.0x
ROE-3.1%
Short Volume16.8%as of 26.07.21
